How to Buy Oramed Pharmaceuticals Stock
Oramed Pharmaceuticals Inc
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides.
Oramed Pharmaceuticals stock last closed at $3.41, up 5.25% from the previous day, and has increased 54.3% in one year. It has overperformed other stocks in the Biotechnology industry by 0.85 percentage points. Oramed Pharmaceuticals stock is currently +87.36% from its 52-week low of $1.82, and -8.09% from its 52-week high of $3.71.
At the moment, there are 39.8M shares of ORMP outstanding. The market capitalization of ORMP is $135.73M. In the past 24 hours, 167,000 ORMP shares were traded.
How to Buy Oramed Pharmaceuticals Stock
Not sure how to invest in Oramed Pharmaceuticals stock? Here's how.
- Decide where to buy Oramed Pharmaceuticals stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you determine where to buy Oramed Pharmaceuticals stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Pick your payment method and add your information.
- Research Oramed Pharmaceuticals stock: The Oramed Pharmaceuticals ticker symbol is ORMP. Is Oramed Pharmaceuticals stock a good investment? Should you buy shares of ORMP? How do ORMP's underlying business fundamentals look? Do top analysts think Oramed Pharmaceuticals is a good buy? Why has ORMP's stock price moved recently? (Hint: Our stock market research website can help you evaluate if ORMP is a good stock to buy).
- Make your ORMP trade: Decide if you will purchase ORMP shares at the current market price or use a limit order to buy ORMP stock at a given price.
- Keep an eye on your investment in ORMP: Create a watchlist to monitor your investment in Oramed Pharmaceuticals stock.
Step 1: Decide where to buy Oramed Pharmaceuticals stock
You need a brokerage account in order to access the NASDAQ market and buy ORMP stock.
Our preferred brokerage: eToro
In our opinion, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global financial markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've selected the best brokerage, you need to fill out some personal details so you are able to buy ORMP today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to create a new trading account.
- Send your info by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've created your account on the highest rated stock app, you need to deposit funds:
Check out the video below for more details depositing money into your new brokerage account.
Step 4: Research Oramed Pharmaceuticals stock
After you have figured out the best place to buy Oramed Pharmaceuticals stock, it's crucial to analyze their stock prior to investing, so you can comprehend the risk and upside.
Overview of key ORMP info
ORMP Due Diligence Checks
WallStreetZen was built to help part-time investors perform better fundamental analysis quickly.
You can view all of the due diligence checks on ORMP's stock page.
Is ORMP stock properly valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge ORMP's intrinsic value.
Using relative valuations metrics:
- ORMP may be undervalued based on its P/E ratio of 3.31x, relative to Biotechnology industry P/E ratio of 234.92x
- ORMP could be undervalued based on its P/B ratio of 0.67x, relative to Biotechnology industry P/B ratio of 5.16x
- ORMP could be undervalued based on its PEG ratio of 0.01x
You can access additional valuation research on ORMP's stock here.
ORMP Financial Summary
Signs that ORMP is financially healthy:
- ORMP has a low debt to equity ratio of 0.09.
- There are more short-term assets than long-term liabilities on the ORMP balance sheet.
- Total ORMP debt is lower than 5 years ago, relative to shareholder equity.
- ORMP has $134.69M in cash and short term investments. This is enough to cover its annual cash burn of $12.74M.
- ORMP has cash burn of 12736000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the ORMP balance sheet.
Metrics for Advanced ORMP Traders
ORMP Performance Numbers
Last year, ORMP earnings were $43.85M. Over the last 1 years, ORMP's earnings have increased by 836.36% per year. This was faster than the Biotechnology industry average of 10.24%.
Last year, ORMP revenue was $2.00M. In the last 5 year, ORMP's revenue has gone up by -5.9% per year. This was slower than the Biotechnology industry average of 42.94%.
Dive into ORMP's earnings and revenue performance here.
Who is buying/selling ORMP?
Over the past year, executives and large shareholders at ORMP have not bought or sold any shares.
Research more about who owns ORMP shares here.
Can I get consistent income from ORMP stock?
Oramed Pharmaceuticals pays a dividend of 7.33%, compared to the Biotechnology industry's average dividend yield of 5.56%. If you owned $1,000 of ORMP stock, you would have been paid $73.31 last year.
Find more data about Oramed Pharmaceuticals dividend yield and history here.
What others are saying about ORMP
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Make your ORMP trade
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally fine. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a given dollar amount limit, use a limit order.
Hit the Open button and your broker will place your order.
If you need more assistance investing in stocks on eToro, click the how to video below:
Step 6: Keep an eye on your investment in ORMP
Now that you own some ORMP shares, you'll want to stay up-to-date on your shares.
Make a watchlist to track the latest developments regarding your ORMP stock.
ORMP Feed
How to Buy Stock in Oramed Pharmaceuticals
To reiterate, here are the 6 steps to buy Oramed Pharmaceuticals stock:
- Decide where to buy Oramed Pharmaceuticals stock
- Sign up for a brokerage account
- Deposit funds into your brokerage account
- Research Oramed Pharmaceuticals stock
- Make your ORMP trade
- Keep an eye on your investment in ORMP
If you need a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get notifications regarding your investment in Oramed Pharmaceuticals, create your watchlist below.
Related Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.